Featured
Last news
Former Cambodian opposition MP shot dead in Bangkok: Thai media
A former Cambodian opposition MP and French citizen was shot dead by a gunman on a motorcycle in Bangkok on Tuesday, Thai media reported.
UK government urges cricket chiefs to 'deliver on own rules' after Afghanistan boycott calls
The UK government says the International Cricket Council should "deliver on their own rules" relating to women's participation as the England men's team resist calls to boycott their upcoming match against Afghanistan.
Quake in China's Tibet kills 126 with tremors felt in Nepal, India
A devastating earthquake in China's remote Tibet region killed at least 126 people and damaged thousands of buildings on Tuesday, state media reported, with tremors also felt in neighbouring Nepal's capital Kathmandu and parts of India.
France remembers Charlie Hebdo attacks 10 years on
France on Tuesday marked 10 years since an Islamist attack on the Charlie Hebdo satirical newspaper that shocked the country and led to fierce debate about freedom of expression and religion.
South Korea rival parties form plane crash task force
South Korea's rival parties agreed Tuesday to form a joint task force to probe the recent Jeju Air plane crash that left 179 people dead, as the transport minister offered to resign over the tragedy.
Georgians hold anti-government protest on Orthodox Christmas
Thousands of Georgians marched through the streets of Tbilisi late on Monday on Orthodox Christmas Eve, gathering in front of parliament for a 40th day of anti-government demonstrations.
Quake in China's Tibet kills 95 with tremors felt in Nepal, India
A devastating earthquake in China's remote Tibet region killed at least 95 people and collapsed "many buildings" on Tuesday, state media reported, with tremors also felt in neighbouring Nepal's capital Kathmandu and parts of India.
S. Korea rival parties form plane crash task force despite political turmoil
South Korea's ruling and opposition parties agreed on Tuesday to form a joint parliamentary task force to probe the recent Jeju Air plane crash that left 179 people dead.
Quake in China's Tibet kills 53 with tremors felt in Nepal, India
A devastating earthquake in China's remote Tibet region killed at least 53 people and collapsed "many buildings" on Tuesday, state media reported, with tremors also felt in neighbouring Nepal's capital Kathmandu and parts of India.
Quake in China's Tibet kills 32 with tremors felt in Nepal, India
A powerful earthquake in China's remote Tibet region killed at least 32 people and collapsed "many buildings" on Tuesday, state media reported, with tremors also felt in neighbouring Nepal's capital Kathmandu and parts of India.
Laxxon Medical to Participate in 27th Annual Needham Growth Conference
Laxxon Medical, a leading pharma-technology company pioneering a new generation of advanced pharmaceuticals, today announced that management is participating in the 27th Annual Needham Growth Conference on January 9-17th, 2024.
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ADHD and schizophrenia, with 1-2 additional IND applications filed in 2025
Allied OMS Continues Strategic Expansion in Texas with Parkway Oral Surgery in Houston
Allied OMS, one of the country's premier management services organizations (MSO) specializing in oral and maxillofacial surgery, is pleased to announce the addition of Parkway Oral Surgery & Dental Implant Center in Houston, Texas to its growing platform, continuing its strategic expansion in Texas and key U.S. markets.
Absinthia Celebrates Feature in New Orleans Magazine Absinthe Spotlight
Cover Story Highlights Absinthe's Cultural Resurgence
Trifecta Launches High-Protein Performance Meals: Raising the Bar in Performance Nutrition
The leading health and fitness-focused meal delivery service in the US expands its offering with a new line of chef-crafted protein-dense meals for active lifestyles
Dolphin Subsidiary, Influencer Marketing Powerhouse, the Digital Dept., Expands BRANDEdit Experiences and Corporate Event Services for 2025
Dolphin Entertainment (NASDAQ:DLPN) subsidiary The Digital Dept. announces the continued growth of its highly successful BRANDEdit influencer showroom experiences and expanded corporate and retail event services for 2025. Following a record-breaking year, The Digital Dept. will introduce its premier brand discovery platform to Nashville while building on the success of its flagship events in Los Angeles and New York.
Quantum Biopharma Ltd. Approved to Dual List on Upstream
Trading to become available January 14th under 'QNTM'
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth
Walmart Marketplace saw a 60% year-over-year growth in gross merchandise volume, with third-party sellers accounting for over 50% of online sales, contributing to Walmart's e-commerce revenue surpassing $100 billion in 2024. This makes it a powerful platform for rapid brand growth and a game-changing opportunity for CBDL's breakthrough product line.
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), an emerging leader in age-reversal science focused on treating the root causes of diseases rather than just their symptoms, announced today potentially groundbreaking findings from a preclinical progeria lifespan study conducted in collaboration with Nagi Bioscience SA. Utilizing C. elegans (nematode) models, in which the study demonstrated restoration of shortened lifespan and normalization of accelerated aging with Telomir-1.
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division
Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeriesKuros will work collaboratively to sell, market and provide support services to Medtronic's sales forceKuros will keep responsibility for contracts, hospital partnerships and the recognition of revenue from salesKuros will continue to sell directly in non-contracted territories as well as in markets outside of spineThis agreement transforms an initial trial agreement into a strategic alliance
Judge rejects Trump request to delay hush money sentencing
A New York judge on Monday rejected US President-elect Donald Trump's request to delay sentencing set for later this week in his hush money case.
Archbishop of Canterbury Justin Welby spends final day in role
Archbishop of Canterbury Justin Welby on Monday spent his final day as leader of the world's Anglicans, nearly two months after resigning over failures in the Church of England's handling of a serial abuse case.
Archbishop of Canterbury Justin Welby faces final day in role
Archbishop of Canterbury Justin Welby will officially step down on Monday as leader of the world's Anglicans, nearly two months after resigning over failures in the Church of England's handling of a serial abuse case.
Protagonist Therapeutics Reports Granting of Inducement Awards
Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on January 2, 2025, it issued inducement awards to Newman Yeilding, M.D., upon his appointment to the role of Executive Vice President, Chief Scientific Officer, in accordance with the terms of his employment offer letter. Dr. Yeilding served in a consultant role as the Company's Chief Scientific Advisor from August 1, 2024 through January 1, 2025. The awards were granted under the Protagonist Therapeutics Amended and Restated Inducement Plan, which was adopted May 29, 2018, and amended February 18, 2020 and February 15, 2022.
Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that CEO, Josh Disbrow, will participate in a webcasted fireside chat at the Lytham Partners 2025 Investor Healthcare Summit, taking place virtually on Monday, January 13, 2025.
Reminder for Pure Cycle Corporation Q1 2025 Earnings Presentation
Pure Cycle Corporation (NASDAQ:PCYO) wishes to express our sincere condolences to the Carter Family in the passing of President Carter and acknowledge the day of mourning on January 9th. While we understand the markets will be closed, we will be holding our previously scheduled earnings presentation on Thursday, January 9, 2025, to discuss the results for the three months ended November 30, 2024. For an interactive experience, including the ability to ask questions and view the slide presentation, please register and join the event via the link below. Call in access will be in listen-only mode. See below for event details.
Soteria Battery Innovation Group will be participating at the DealFlow Events Microcap Conference
Soteria Battery Innovation Group, a corporation dedicated to battery safety will participate in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia
CASI Pharmaceuticals, Inc. (Nasdaq:CASI), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products announced that the first patient has been dosed in the Phase 1/2 trial to evaluate the safety and tolerability of CID-103 in adult patients with chronic Immune Thrombocytopenia (ITP) in China.
Genflow Biosciences PLC Announces 2024 Highlights
Genflow Biosciences Plc("Genflow" or "the Company")A Look Back at an Exciting 2024
New Orleans attacker had recorded street using Meta glasses: FBI
The man accused of the ramming attack that killed 14 revelers on a crowded New Orleans street had earlier visited the city on apparent reconnaissance missions, once recording the location using camera-equipped glasses, investigators said Sunday.
Albanian Orthodox archbishop in critical condition
The head of the Albanian Orthodox Church, who was airlifted to a hospital in Athens due to complications from a virus, is in a critical condition, the Evangelismos hospital said Sunday.